| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
25,230,000 |
| Market
Cap: |
303.26(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$4.8 - $14.07 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Verastem is a late stage development biopharmaceutical company, with ongoing registration directed trials, focused on developing and commercializing medicines for patients battling cancer. Co.'s product candidates, VS-6766 and defactinib, are being investigated in both preclinical and clinical studies for the treatment of various solid tumors. VS-6766 is an orally available small molecule rapidly accelerated fibrosarcoma/ mitogen-activated protein kinase kinase clamp. Defactinib is an oral small molecule inhibitor of Focal Adhesion Kinase and proline-rich tyrosine kinase that is being evaluated as a potential combination therapy for various solid tumors.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
1,735 |
21,833 |
25,311 |
165,018 |
| Total Sell Value |
$18,442 |
$258,319 |
$292,764 |
$385,800 |
| Total People Sold |
4 |
4 |
4 |
4 |
| Total Sell Transactions |
9 |
20 |
37 |
63 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Paterson Dan |
President and CEO |
• • – |
2023-09-19 |
4 |
S |
$9.84 |
$1,801 |
D/D |
(183) |
87,343 |
|
-30% |
|
| Gagnon Robert E. |
Director |
– • – |
2023-09-18 |
4 |
S |
$9.91 |
$2,755 |
D/D |
(278) |
46,756 |
|
-16% |
|
| Stuglik Brian M |
Director |
– • – |
2023-09-18 |
4 |
S |
$9.91 |
$4,737 |
D/D |
(478) |
91,485 |
|
-16% |
|
| Paterson Dan |
President and CEO |
• • – |
2023-09-18 |
4 |
S |
$9.91 |
$2,378 |
D/D |
(240) |
87,526 |
|
-16% |
|
| Paterson Dan |
President and CEO |
• • – |
2023-08-02 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
87,766 |
|
- |
|
| Calkins Daniel |
Vice President of Finance |
• – – |
2023-07-06 |
4 |
S |
$8.02 |
$40 |
D/D |
(5) |
8,694 |
|
20% |
|
| Calkins Daniel |
Vice President of Finance |
• – – |
2023-06-26 |
4 |
S |
$8.17 |
$212 |
D/D |
(26) |
8,422 |
|
26% |
|
| Stuglik Brian M |
Chief Executive Officer |
• • – |
2023-06-20 |
4 |
S |
$10.30 |
$2,833 |
D/D |
(275) |
91,963 |
|
31% |
|
| Gagnon Robert E. |
Director |
– • – |
2023-06-20 |
4 |
S |
$10.30 |
$1,339 |
D/D |
(130) |
47,034 |
|
31% |
|
| Paterson Dan |
President and COO |
• – – |
2023-06-20 |
4 |
S |
$10.30 |
$1,885 |
D/D |
(183) |
37,766 |
|
31% |
|
| Stuglik Brian M |
Chief Executive Officer |
• • – |
2023-06-16 |
4 |
S |
$9.92 |
$4,831 |
D/D |
(487) |
92,238 |
|
36% |
|
| Gagnon Robert E. |
Director |
– • – |
2023-06-16 |
4 |
S |
$9.92 |
$2,807 |
D/D |
(283) |
47,164 |
|
36% |
|
| Paterson Dan |
President and COO |
• – – |
2023-06-16 |
4 |
S |
$9.92 |
$2,420 |
D/D |
(244) |
37,949 |
|
36% |
|
| Calkins Daniel |
Vice President of Finance |
• – – |
2023-04-05 |
4 |
S |
$0.37 |
$28 |
D/D |
(75) |
101,397 |
|
-88% |
|
| Calkins Daniel |
Vice President of Finance |
• – – |
2023-03-24 |
4 |
S |
$0.42 |
$159 |
D/D |
(378) |
101,472 |
|
-105% |
|
| Gagnon Robert E. |
Director |
– • – |
2023-03-20 |
4 |
S |
$0.43 |
$716 |
D/D |
(1,664) |
569,399 |
|
-90% |
|
| Paterson Dan |
President and COO |
• – – |
2023-03-20 |
4 |
S |
$0.43 |
$1,006 |
D/D |
(2,339) |
458,351 |
|
-90% |
|
| Stuglik Brian M |
Chief Executive Officer |
• • – |
2023-03-20 |
4 |
S |
$0.43 |
$1,508 |
D/D |
(3,508) |
1,112,736 |
|
-90% |
|
| Gagnon Robert E. |
Director |
– • – |
2023-03-16 |
4 |
S |
$0.40 |
$1,462 |
D/D |
(3,654) |
571,063 |
|
-76% |
|
| Paterson Dan |
President and COO |
• – – |
2023-03-16 |
4 |
S |
$0.40 |
$1,255 |
D/D |
(3,138) |
460,690 |
|
-76% |
|
| Stuglik Brian M |
Chief Executive Officer |
• • – |
2023-03-16 |
4 |
S |
$0.40 |
$2,510 |
D/D |
(6,276) |
1,116,244 |
|
-76% |
|
| Calkins Daniel |
Vice President of Finance |
• – – |
2023-01-05 |
4 |
S |
$0.43 |
$32 |
D/D |
(74) |
98,517 |
|
6% |
|
| Calkins Daniel |
Vice President of Finance |
• – – |
2022-12-27 |
4 |
S |
$0.33 |
$411 |
D/D |
(1,246) |
98,591 |
|
-27% |
|
| Paterson Dan |
President and COO |
• – – |
2022-12-19 |
4 |
S |
$0.37 |
$1,093 |
D/D |
(2,954) |
463,828 |
|
-16% |
|
| Stuglik Brian M |
Chief Executive Officer |
• • – |
2022-12-19 |
4 |
S |
$0.37 |
$1,316 |
D/D |
(3,556) |
1,122,520 |
|
-16% |
|
168 Records found
|
|
Page 2 of 7 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.17 (1.43%) 
